Relmada Therapeutics Files Proxy Statement
Ticker: RLMD · Form: DEF 14A · Filed: Apr 11, 2025 · CIK: 1553643
| Field | Detail |
|---|---|
| Company | Relmada Therapeutics, Inc. (RLMD) |
| Form Type | DEF 14A |
| Filed Date | Apr 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, annual-meeting, corporate-governance
TL;DR
Relmada proxy filed, annual meeting May 23. Vote your shares!
AI Summary
Relmada Therapeutics, Inc. filed its definitive proxy statement on April 11, 2025, for its annual meeting on May 23, 2025. The company, formerly known as Camp Nine, Inc., is incorporated in Nevada and operates in the pharmaceutical preparations sector. Its business and mailing address are located at 2222 Ponce de Leon Blvd., 3rd Floor, Coral Gables, FL 33134.
Why It Matters
This filing provides shareholders with essential information regarding the upcoming annual meeting, including details about director nominations, executive compensation, and other corporate governance matters, allowing them to make informed voting decisions.
Risk Assessment
Risk Level: low — This is a routine filing of a proxy statement for an annual shareholder meeting, which typically involves standard corporate governance procedures.
Key Players & Entities
- Relmada Therapeutics, Inc. (company) — Registrant
- Camp Nine, Inc. (company) — Former company name
- 20250411 (date) — Filing date
- 20250523 (date) — Annual meeting date
- 2222 Ponce de Leon Blvd. (location) — Business address
FAQ
What is the purpose of this DEF 14A filing?
This filing is a definitive proxy statement filed by Relmada Therapeutics, Inc. for its annual shareholder meeting scheduled for May 23, 2025.
When was this proxy statement filed with the SEC?
The definitive proxy statement was filed on April 11, 2025.
What was Relmada Therapeutics, Inc. formerly known as?
Relmada Therapeutics, Inc. was formerly known as Camp Nine, Inc.
Where is Relmada Therapeutics, Inc. located?
The company's business and mailing address is 2222 Ponce de Leon Blvd., 3rd Floor, Coral Gables, FL 33134.
What is the fiscal year end for Relmada Therapeutics, Inc.?
The company's fiscal year ends on December 31.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on April 11, 2025 regarding RELMADA THERAPEUTICS, INC. (RLMD).